Rheumatologist denounces common practice as a time-draining impediment to patient care
The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market
With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases
Coding Corner Question: March
Coding for chemotherapy infusion with a drug reaction
Beware Antitrust Laws When Considering Healthcare Mergers
Analysis of laws governing collaboration of healthcare systems, hospitals and physician practices should be done before consolidating
Rheumatology Practice Merger Pros and Cons
What physicians should consider before they add partners, expand their practice
Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists
Patients with conditions that don’t resolve with topical steroids are signal for referral
Design a Compliance Plan for Your Rheumatology Practice
Tips for creating, maintaining and enforcing an effective plan
Coding Corner Answer: March
Coding for chemotherapy infusion with a drug reaction
Changes to Rheumatology Maintenance of Certification Program Imminent
The ACR supports revisions planned by the American Board of Internal Medicine to modify its MOC program
Respect Rheumatologists as Responsible Adults: A Call for MOC Reform
A rheumatologist says current maintenance of certification requirements put unnecessary stress on clinicians
- « Previous Page
- 1
- …
- 94
- 95
- 96
- 97
- 98
- …
- 170
- Next Page »